Valor Medical, Inc., a medical device company, develops a liquid embolic/malleable polymetric flow diverter technology for the treatment of cerebral aneurysms. The company provides Neucrylate, a derivative of cyanoacrylate monomer, which changes from liquid to a sponge like material when it comes in contact with blood. Its product serves